Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaele C Christian

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Cancer treatment and the older patientEdward L Trimble, Michaele C Christian
Drugs|September 1, 1993
New cisplatin analogues in development. A reviewRaymond B Weiss, Michaele C Christian
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2003
Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trialsMichaele C Christian, Edward L Trimble
Gynecologic Oncology|December 22, 2005
Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinomaEdward L Trimble, Michaele C Christian
Cancer Treatment and Research|February 20, 2007
NCI's cancer therapy evaluation program: a commitment to treatment trialsJeffrey S Abrams, Anthony Murgo, Michaele C Christian
Gynecologic Oncology|October 10, 2006
The future of phase II trialsJohn Farley, Michael J Birrer, Michaele C Christian
The Oncologist|May 2, 2008
Intraperitoneal chemotherapy for women with epithelial ovarian cancerEdward L Trimble, Sharon Thompson, Michaele C Christian, et al.
Journal of Biopharmaceutical Statistics|April 23, 2009
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experienceElisabeth I Heath, Patricia M LoRusso, S Percy Ivy, et al.
The New England Journal of Medicine|May 3, 2002
A central institutional review board for multi-institutional trialsMichaele C Christian, Jacquelyn L Goldberg, Jack Killen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trialsWarren B Sateren, Edward L Trimble, Jeffrey Abrams, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Cancer treatment and the older patientEdward L Trimble, Michaele C Christian
Drugs|September 1, 1993
New cisplatin analogues in development. A reviewRaymond B Weiss, Michaele C Christian
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2003
Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trialsMichaele C Christian, Edward L Trimble
Gynecologic Oncology|December 22, 2005
Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinomaEdward L Trimble, Michaele C Christian
Cancer Treatment and Research|February 20, 2007
NCI's cancer therapy evaluation program: a commitment to treatment trialsJeffrey S Abrams, Anthony Murgo, Michaele C Christian
Gynecologic Oncology|October 10, 2006
The future of phase II trialsJohn Farley, Michael J Birrer, Michaele C Christian
The Oncologist|May 2, 2008
Intraperitoneal chemotherapy for women with epithelial ovarian cancerEdward L Trimble, Sharon Thompson, Michaele C Christian, et al.
Journal of Biopharmaceutical Statistics|April 23, 2009
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experienceElisabeth I Heath, Patricia M LoRusso, S Percy Ivy, et al.
The New England Journal of Medicine|May 3, 2002
A central institutional review board for multi-institutional trialsMichaele C Christian, Jacquelyn L Goldberg, Jack Killen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trialsWarren B Sateren, Edward L Trimble, Jeffrey Abrams, et al.
Pageof 1